Medtronic has not publicly terminated business relationships based on views or beliefs. Medtronic PLC scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with Human Rights Campaign’s controversial demands, Medtronic increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Medtronic forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company does not protect its employees against viewpoint discrimination. Medtronic likely covers travel costs for employee abortions. The company is a member of the PGLE, a bronze sponsor of Out and Equal, and a corporate partner of the NGLCC. Medtronic uses its reputation and corporate dollars to support LGBTQ causes and organizations. The company holds educational trainings for employees on "systemic racism" and its former CEO is a signatory of the Business Roundtable's 2019 Statement on the Purpose of Corporation, which promotes stakeholder capitalism. Medtronic opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. For these reasons, Medtronic receives a High Risk rating.